|
|
|
|
|
|
|
-
13 Nonclinical Toxicology
|
|
|
|
|
|
-
16 How Supplied/storage And Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
-
17 Patient Counseling Information
|
|
|
|
|
|
-
Spl Patient Package Insert Section
|
|
|
|
|
|
-
Package Label.principal Display Panel
|
|
|
|
|
|
-
2 D Osage And Administration
|
|
|
-
Dose once daily. Titrate as needed to a maximum dose of 320/25mg (2) May be used as add-on/switch therapy for patients not adequately controlled on any of the components (valsartan or HCTZ) (2) May be substituted for titrated components (2.3)
|
|
|
-
3 Dosage Forms And Strengths
|
|
|
-
Tablets (valsartan/HCTZ mg): 80/12.5, 160/12.5, 160/25, 320/12.5, 320/25
|
|
|
|
|
|
|
-
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue Diovan HCT as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1)
|
|
|